Fomepizole Injection, Solution
Product Images NDC 68475-510
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fomepizole (NDC 68475-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
730ed7cf 45d8 4e50 A135 B106d0aef11b 02
The scanned text seems to be a warning for Fomepizole Injection, which is meant only for intravenous infusion and should be used cautiously. The injection is available in a 15mL container and its strength is 1.5a/15mL. The text also contains dosages of the injection, one of which is given as 2'553'77-13. Not much information can be derived from the given text as it contains several errors and misplaced characters.*
730ed7cf 45d8 4e50 A135 B106d0aef11b 03
This is a description for an intravenous injection called Fomepizole. Its National Drug Code (NDC) is 68475-510-01. The injection comes in vials of 1g/1.5 mL and 1.5g/1.5 mL concentration, with instructions for dosage and administration available at code NoKR/DRUGS/KIKI28/269/97. Caution is advised for users not to use it with polycarbonate-containing syringes or needles and to dilute it before use. The injection is meant for single-use only and should be stored at a controlled room temperature of 68°-77°F. The manufacturer of Fomepizole is Navinta LLC, and the package was created on July 12, 2018.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.